[Chinese Expert Consensus on Assessment and Clinical Application of 
Tertiary Lymphoid Structure for Non-small Cell Lung Cancer (2025 Version)]

  • ,

Summary

This summary is machine-generated.

Tertiary lymphoid structures (TLS) are vital in the tumor microenvironment and show promise as cancer biomarkers. This consensus provides standardized guidelines for assessing TLS in non-small cell lung cancer (NSCLC) to aid clinical application.

Area Of Science

  • Oncology
  • Immunology
  • Pathology

Background

  • Tertiary lymphoid structures (TLS) significantly impact the tumor microenvironment, influencing cancer progression.
  • TLS are emerging biomarkers for predicting prognosis and treatment response in cancer patients.
  • Current lack of standardized TLS evaluation criteria hinders clinical translation, especially across diverse tumor tissues.

Purpose Of The Study

  • To establish standardized criteria for the definition, clinical significance, testing, and assessment of TLS in non-small cell lung cancer (NSCLC).
  • To address the clinical diagnosis and treatment needs for NSCLC by normalizing TLS assessment.
  • To enhance clinician and pathologist understanding and application of TLS detection in NSCLC.

Main Methods

  • Consensus development based on relevant research and Chinese clinical practice.
  • Focus on defining TLS, its clinical significance, and appropriate assessment methods.
  • Development of standardized and normalized suggestions for clinical assessment and application.

Main Results

  • Provides standardized suggestions for the clinical assessment and application of TLS in NSCLC.
  • Aims to improve understanding and consistency in TLS evaluation among healthcare professionals.
  • Establishes a reference basis for the clinical application of TLS detection in NSCLC.

Conclusions

  • Standardized assessment of TLS in NSCLC is crucial for clinical translation.
  • This consensus offers practical guidelines to overcome current challenges in TLS evaluation.
  • Improved understanding and application of TLS will benefit NSCLC patient prognosis and treatment.